MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,768,986
Net Income
-$277,601
Net Profit Margin
-15.69%
Unit: Dollar
Revenue Breakdown
Product
License
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
1,768,986
1,302,115
1,096,830
1,032,096
Costs of sales
598,959
452,388
408,461
406,721
Gross profit
1,170,027
849,727
688,369
625,375
Selling, general and administrative
1,336,579
1,296,193
1,267,707
1,165,517
Total operating expenses
1,336,579
1,296,193
1,267,707
1,165,517
Loss from operations
-166,552
-446,466
-579,338
-540,142
Interest income (expense), net
-114,066
-175,282
-771
409
Gain on settlement of legacy accounts payable obligations
-
-
0
-
Other income
3,017
3,282
1,629
1,814
Loss before benefit for income taxes
-
-
-578,480
-
Total other income (expenses)
-111,049
-172,000
-
2,223
Net loss
-277,601
-618,466
-578,480
-537,919
Basic EPS
-0.01
-0.01
-0.012
-0.01
Basic Average Shares
48,407,917
48,285,303
48,072,299
47,539,384
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Product
$1,691,045
(170.48%↑ Y/Y)
License
$77,941
(3.92%↑ Y/Y)
Net loss
-$277,601
(57.27%↑ Y/Y)
Revenue
$1,768,986
(152.64%↑ Y/Y)
Loss from operations
-$166,552
(74.46%↑ Y/Y)
Total other income
(expenses)
-$111,049
(-4859.92%↓ Y/Y)
Gross profit
$1,170,027
(116.33%↑ Y/Y)
Other income
$3,017
(155.68%↑ Y/Y)
Costs of sales
$598,959
(275.88%↑ Y/Y)
Total operating
expenses
$1,336,579
(12.05%↑ Y/Y)
Interest income
(expense), net
-$114,066
(-9992.97%↓ Y/Y)
Selling, general and
administrative
$1,336,579
(12.05%↑ Y/Y)
Buy us a coffee
Nuo Therapeutics, Inc. (AURX)
Nuo Therapeutics, Inc. (AURX)